94186 ⎘
Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
TOPICAL THERAPEUTIC FORMULATIONS
#2BENZOTRIAZOLE COMPOUND
#3PIPERIDINONE DERIVATIVE OR SALT THEREOF, HARMFUL ORGANISM CONTROL AGENT CONTAINING SAID COMPOUND, AND METHOD FOR USING SAME
#4TOPICAL THERAPEUTIC FORMULATIONS
#5ARYL TETRAHYDROPYRIDINE DERIVATIVE OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAME, AND METHOD FOR USE THEREOF
#6C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
#7SALTS AND SOLID STATE FORMS OF A KIF18A INHIBITOR COMPOUND
#8INVERSE ELECTRON DEMAND DIELS-ALDER TYPE HETEROCYCLE SYNTHESIS WITH 1,2,3-TRIAZINE 1-OXIDES
#9Topical therapeutic formulations
#10COMPOUNDS HAVING INHIBITORY EFFECT ON MITOCHONDRIAL HYPERFISSION
#11POTENT AND SELECTIVE INHIBITORS OF THE CALCIUM-ACTIVATED POTASSIUM CHANNEL, KCA3.1, FOR USE AS PLATFORM THERAPEUTICS
#12QUATERNARY HETEROATOM CONTAINING COMPOUNDS
#13Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury
#14Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
#15Topical therapeutic formulations
#16AMLODIPINE MESYLATE MONOHYDRATE PREPARATION METHOD THEREFOR AND USE THEREOF
#17Drug-induced activation of the Reelin signaling system
#18C-carbon linked glutarimide degronimers for target protein degradation
#19Drp1-FILAMIN COMPLEX FORMATION INHIBITORS
#20PEROVSKITES FOR PHOTOCATALYTIC ORGANIC SYNTHESIS
#21Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury
#22Prodrugs of glutamine analogs
#23ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS
#24Quaternary heteroatom containing compounds
#25Drug-induced activation of the Reelin signaling system
#26Compositions and methods for the treatment of seizure caused by brain tumor
#27Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#28Quaternary heteroatom containing compounds
#29Topical therapeutic formulations
#30Compounds and methods of treating or ameliorating an IL-1R-mediated disease or disorder using same
#31Prodrugs of glutamine analogs
#32Prodrugs of glutamine analogs
#33Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#341,4-dihydropyridine derivatives with HSP modulating activity
#35SMALL MOLECULE INHIBITORS OF NECROPTOSIS
#36C3-carbon linked glutarimide degronimers for target protein degradation
#37Quaternary heteroatom containing compounds
#38Prodrugs of glutamine analogs
#39Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#40Compounds and methods for the treatment of neurodegenerative diseases
#41COMPOSITIONS AND METHODS FOR THE TREATMENT OF GLIOBLASTOMA
#42Compounds useful as immunomodulators
#43Compounds and methods of treating or ameliorating an IL-1R-mediated disease or disorder using same
#44SMALL MOLECULE INHIBITORS OF NECROPTOSIS
#45Dihydropyridinone MGAT2 inhibitors
#46Arylhydrazides containing a 2-pyridone moiety as selective antibacterial agents
#47Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#482-oxo-3,4-dihydropyridine-5-carboxylates and their use
#49Quaternary heteroatom containing compounds
#50DIHYDROPYRIDINONE MGAT2 INHIBITORS
#51Topical therapeutic formulations
#52Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#53Oxidisable pyridine derivatives, their preparation and use as anti-alzheimer agents
#54Solid betalain compositions and methods
#55Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#56Partially saturated nitrogen-containing heterocyclic compound
#57Topical therapeutic formulations
#58Dihydropyridinone MGAT2 inhibitors
#59Oligomer-calcium channel blocker conjugates
#601,4-dihydropyridine derivatives with Hsp modulating activity
#61Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof
#62METHOD FOR PURIFICATION OF CALCIUM CHANNEL BLOCKERS OF DIHYDORPYRIDINE TYPE AND PREPARATION OF NANOPARTICLES THEREOF
#63Small molecule inhibitors of necroptosis
#64Substituted heterocyclic compounds
#65Topical therapeutic formulations
#66Compounds And Compositions For Treating Cancer
#67Aryl dihydropyridinone and piperidinone MGAT2 inhibitors
#68DERIVATIVES OF 1,4-DIHYDROPYRIDINE POSSESSING ANTIVIRAL EFFICACY
#69Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof
#70NOVEL COMPOUNDS WITH HIGH THERAPEUTIC INDEX
#71Polymorphic forms of manidipine
#72SMALL MOLECULE INHIBITORS OF NECROPTOSIS
#73Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
#74Compounds and compositions for treating cancer
#75Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine and its use in the treatment of cancer
#76Prodrugs containing novel bio-cleavable linkers
#77Prodrugs containing novel bio-cleavable linkers
#78Prodrugs containing novel bio-cleavable linkers
#79Dihydropyridine calcium antagonist compounds, preparation methods, and medical uses thereof
#80Oligomer-calcium channel blocker conjugates
#81Anti-infective derivatives, method for the production thereof, pharmaceutical compositions containing same and uses of said derivatives in treatment
#82PROCESS FOR PREPARING LERCANIDIPINE HYDROCHLORIDE
#83Process for producing enantiomer of amlodipine in high optical purity
#84Process for the preparation of 6-(aryl)-4-aminopicolinates
#85Substituted heterocyclic compounds
#86Genipin derivatives and uses thereof
#87Dihydropyridone amides as P2Xmodulators
#88Stabilized pharmaceutical compositions containing a calcium channel blocker
#89Stabilized pharmaceutical compositions containing a calcium channel blocker
#90METHOD OF PREPARING S-(-)-AMLODIPINE OR A SALT THEREOF AND AN INTERMEDIATE USED THEREIN
#91Process for the preparation of lercanidipine
#92Solid betalain compositions and methods
#93Crystalline S-(−)-amlodipine adipic acid salt anhydrous and preparation method thereof
#94L-THREONINE DERIVATIVES OF HIGH THERAPEUTIC INDEX
#95L-threonine derivatives of high therapeutic index
#96Method for the separation of S-(−)-amlodipine from racemic amlodipine
#97Method of preventing dihydropyridine compound from degradation
#98L-Threonine derivatives of high therapeutic index
#99(S)-(-)-Amlodipine Camsylate or Hydrate Thereof And Pharmaceutical Composition Comprising Same
#100COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROIDAL RECEPTORS AND CALCIUM CHANNEL ACTIVITIES
#101Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
#102Process for the preparation of lercanidipine
#103Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof
#104SUBSTITUTED HETEROCYCLIC COMPOUNDS
#105Substituted Heteroarylalkanoic Acids
#106Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
#107SUBSTITUTED HETEROCYCLIC COMPOUNDS
#108Process for Preparation of Chiral Amlodipine Gentisate
#109Process for producing enantiomer of amlodipine in high optical purity
#110Compounds that inhibit cholinesterase
#111Optical resolution method of amlodipine
#112Dihydropyridine derivatives as useful as protein kinase inhibitors
#113RAMIPRIL-AMLODIPINE SALT
#114Derivatives of Aminobutanoic Acid Inhibiting Cpt
#115PROCESS FOR MAKING AMLODIPINE, DERIVATIVES THEREOF, AND PRECURSORS THEREFOR
#116Dihydropyridinone derivatives
#117S-(-)-amlodipine nicotinate and process for the preparation thereof
#118Genipin derivatives and uses thereof
#119PROCESS FOR PREPARING AMLODIPINE
#120Abnormal cannabidiols as agents for lowering intraocular pressure
#121Method for Purificaion of Amlodipine Free Base
#122Dihydropyridine derivatives for use as human neutrophil elastase inhibitors
#123Processes for the preparation of S-(-)-amlodipine
#124Stabilized pharmaceutical compositions containing a calcium channel blocker
#125Aralkyl ester soft drugs
#126Amlodipine gentisate and a method of its preparation
#127Amlodipine nicotinate and process for the preparation thereof
#128Method for the enantiomoeric separation of optical active amlodipine
#129Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity
#130PROCESS FOR PREPARING LACIDIPINE
#131Substituted anilinic piperidines as MCH selective antagonists
#132Crystalline forms of amlodipine maleate
#133Amide derivative of amlodipine
#134L-Threonine derivatives of high therapeutic index
#135Compounds with high therapeutic index
#136Method and compositions for temporarily incapacitating subjects
#137Substituted alkyl amido piperidines
#138Amorphous lercanidipine hydrochloride and uses thereof
#139Prodrugs containing novel bio-cleavable linkers
#140Solid lercanidipine free base
#141Process for making amlodipine, derivatives thereof, and precursors therefor
#142Genipin derivatives and uses thereof
#143Stable amorphous amlodipine camsylate, process for preparing same and composition for oral administration thereof
#144Dihydropyridinone derivatives
#145Substituted alkyl amido piperidines
#146Lercanidipine salts
#147Prodrugs containing novel bio-cleavable linkers
#148Substituted alkyl amido piperidines
#149(S)-Amlodipine malate
#150(S)-amlodipine malate
#151Processes for the preparation of S-(-)-amlodipine
#152S-(−)-amlodipine nicotinate and process for the preparation thereof
#153Industrial process for the synthesis of isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridine dicarboxylate (nisoldipine)
#154Novel crude and crystalline forms of lercanidipine hydrochloride
#155Novel crude and crystalline forms of lercanidipine hydrochloride
#156Process for the preparation of S(−) amlodipine-L(+)-hemi taratarte
#1571,4-dihydro-1,4-diphenylpyridine derivatives
#1581,4-dihydropyridine and pyridine compounds as calcium channel blockers
#159Process for making amlodipine, derivatives thereof, and precursors therefor
#160Method of resolving amlodipine racemate
#1611,4-Dihydropyridine derivative with a guaiacoxypropanolamine and/or phenoxypropanolamine moiety
#162Ursolic acid derivatives